URAT1, a uric acid reabsorption protein, is responsible for about 90% of uric acid reabsorption in the kidneys, making it a key therapeutic target for hyperuricemia treatment (Yusnaini et al., 2023). Here, SLC22A12 is linked to hyperuricemia.